Amnon Hoffman

7.7k total citations
138 papers, 6.3k citations indexed

About

Amnon Hoffman is a scholar working on Oncology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Amnon Hoffman has authored 138 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 36 papers in Molecular Biology and 36 papers in Pharmaceutical Science. Recurrent topics in Amnon Hoffman's work include Drug Solubulity and Delivery Systems (29 papers), Advanced Drug Delivery Systems (21 papers) and Drug Transport and Resistance Mechanisms (19 papers). Amnon Hoffman is often cited by papers focused on Drug Solubulity and Delivery Systems (29 papers), Advanced Drug Delivery Systems (21 papers) and Drug Transport and Resistance Mechanisms (19 papers). Amnon Hoffman collaborates with scholars based in Israel, United States and Germany. Amnon Hoffman's co-authors include Arik Dahan, Chaim Gilon, Horst Kessler, Jayanta Chatterjee, Michael Friedman, Abraham J. Domb, Eran Lavy, Eytan A. Klausner, Pavel Gershkovich and Irina Cherniakov and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Amnon Hoffman

137 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amnon Hoffman Israel 45 2.3k 2.2k 994 824 730 138 6.3k
Tomi Järvinen Finland 41 1.5k 0.6× 2.0k 0.9× 631 0.6× 1.2k 1.5× 1.4k 1.9× 125 6.4k
Valentino J. Stella United States 47 3.1k 1.3× 2.7k 1.2× 1.2k 1.2× 1.5k 1.8× 689 0.9× 185 9.0k
Vincent H.L. Lee United States 39 2.3k 1.0× 1.8k 0.8× 789 0.8× 271 0.3× 305 0.4× 136 5.7k
Shozo Muranishi Japan 37 2.3k 1.0× 1.6k 0.7× 869 0.9× 344 0.4× 269 0.4× 232 5.0k
Shinji Yamashita Japan 42 2.9k 1.3× 1.4k 0.6× 1.6k 1.6× 339 0.4× 349 0.5× 167 5.8k
René Holm Denmark 46 4.7k 2.0× 1.9k 0.8× 1.1k 1.1× 756 0.9× 353 0.5× 266 8.3k
Jarkko Rautio Finland 31 617 0.3× 2.1k 1.0× 977 1.0× 1.0k 1.2× 350 0.5× 88 5.0k
Donald W. Miller United States 50 667 0.3× 2.2k 1.0× 2.0k 2.0× 467 0.6× 385 0.5× 155 7.8k
Lajos Szente Hungary 42 1.9k 0.8× 1.7k 0.8× 474 0.5× 857 1.0× 250 0.3× 186 6.2k
Sanjula Baboota India 60 6.4k 2.7× 3.2k 1.4× 451 0.5× 708 0.9× 685 0.9× 282 12.0k

Countries citing papers authored by Amnon Hoffman

Since Specialization
Citations

This map shows the geographic impact of Amnon Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amnon Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amnon Hoffman more than expected).

Fields of papers citing papers by Amnon Hoffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amnon Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amnon Hoffman. The network helps show where Amnon Hoffman may publish in the future.

Co-authorship network of co-authors of Amnon Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Amnon Hoffman. A scholar is included among the top collaborators of Amnon Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amnon Hoffman. Amnon Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffman, Amnon, et al.. (2025). Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope–Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice. Investigative Ophthalmology & Visual Science. 66(1). 13–13.
2.
Hoffman, Amnon, et al.. (2024). The Synthesis of SNAC Phenolate Salts and the Effect on Oral Bioavailability of Semaglutide. Molecules. 29(16). 3909–3909. 2 indexed citations
3.
Hoffman, Amnon, et al.. (2022). PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design. Molecular Cancer Therapeutics. 21(9). 1415–1429. 3 indexed citations
4.
Bohrisch, J., Christian Schmidt, Eli Breuer, et al.. (2020). The Effect of Chemical Modifications of Chitosan on Intestinal Permeability and Oral Bioavailability of Carbamoylphosphonate JS403. Journal of Bioequivalence & Bioavailability. 12(2). 1–8. 3 indexed citations
5.
Izgelov, Dvora, Abraham J. Domb, & Amnon Hoffman. (2020). The effect of piperine on oral absorption of cannabidiol following acute vs. chronic administration. European Journal of Pharmaceutical Sciences. 148. 105313–105313. 12 indexed citations
6.
7.
Fanous, Joseph, et al.. (2015). Superiority of the S,S conformation in diverse pharmacological processes: Intestinal transport and entry inhibition activity of novel anti-HIV drug lead. International Journal of Pharmaceutics. 495(2). 660–663. 4 indexed citations
8.
Nedvetzki, Shlomo, et al.. (2011). Orally Active, Antimetastatic, Nontoxic Diphenyl Ether‐Derived Carbamoylphosphonate Matrix Metalloproteinase Inhibitors. ChemMedChem. 6(8). 1471–1477. 11 indexed citations
9.
Eyal, Sara, et al.. (2009). The Role of P-Glycoprotein in Intestinal Transport versus the BBB Transport of Tetraphenylphosphonium. Molecular Pharmaceutics. 6(6). 1883–1890. 7 indexed citations
10.
Haroutiunian, Simon, Shimon Lecht, Arik A. Zur, Amnon Hoffman, & Elyad Davidson. (2009). The Challenge of Pain Management in Patients With Myasthenia Gravis. Journal of Pain & Palliative Care Pharmacotherapy. 23(3). 242–260. 16 indexed citations
11.
Dahan, Arik, et al.. (2009). The Solubility–Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to Progesterone. Journal of Pharmaceutical Sciences. 99(6). 2739–2749. 188 indexed citations
13.
Hoffman, Amnon, David Stepensky, Eran Lavy, et al.. (2004). Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. International Journal of Pharmaceutics. 277(1-2). 141–153. 98 indexed citations
14.
Stepensky, David, Lilach Kleinberg, & Amnon Hoffman. (2003). Bone as an Effect Compartment. Clinical Pharmacokinetics. 42(10). 863–881. 45 indexed citations
15.
Golomb, Gershon, Ivan S. Alferiev, Asher Ornoy, et al.. (1996). Novel Bisphosphonates for Calcium-Related Disorders. Phosphorus, sulfur, and silicon and the related elements. 109(1). 221–224. 3 indexed citations
16.
Golomb, Gershon, Iftach Shaked, & Amnon Hoffman. (1995). Intrauterine administration of peptide drugs for systemic effect. Advanced Drug Delivery Reviews. 17(2). 179–190. 10 indexed citations
17.
Hoffman, Amnon & G Lévy. (1990). Kinetics of Drug Action in Disease States. XXXVI: Effect of Cyclosporine on the Pharmacodynamics and Pharmacokinetics of a Barbiturate (Heptabarbital) in Rats. Journal of Pharmaceutical Sciences. 79(1). 19–22. 14 indexed citations
18.
Hoffman, Amnon & Gerhard Levy. (1989). Effect of enoxacin on theophylline neurotoxicity. Life Sciences. 44(23). 1803–1806. 4 indexed citations
20.
Hoffman, Amnon, et al.. (1967). A study of the volatile flavouring constituents of canned Malayan pineapple. Journal of the Science of Food and Agriculture. 18(3). 106–110. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026